Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).
暂无分享,去创建一个
F. Lordick | C. Punt | M. Ducreux | Y. Hotko | T. Ciuleanu | E. Chan | S. Patterson | M. Peeters | T. Price | A. Cervantes | T. André | A. Sobrero | E. Cutsem | K. Oliner | R. Sidhu | G. Wilson | A. Strickland | L. Roman | A. S. Jung | Hua Yu | E. Chan